Clonal hematopoiesis of indeterminate potential and risk of immune thrombocytopenia
CHIP was associated with an increased risk of being diagnosed with ITP, particularly for CHIP with JAK2 or SRSF2 mutation. These findings call for clinical awareness of the risk of ITP among individuals with CHIP.
Authors
- Tove Wästerlid (ORCID: https://orcid.org/0000-0002-4281-0349)
- Karin E. Smedby (ORCID: https://orcid.org/0000-0002-2104-3320)
- Erik Boberg
- Qianwei Liu (ORCID: https://orcid.org/0000-0002-4687-100X)
- Huiwen Xue (ORCID: https://orcid.org/0009-0009-8422-8275)
- Fang Fang (ORCID: https://orcid.org/0000-0002-3310-6456)
- Xinyuan Liu (ORCID: https://orcid.org/0000-0002-3914-9035)
Institutions
- Karolinska University Hospital (SE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Karolinska Institutet (SE)
- Nanfang Hospital (CN)
- Institute of Hematology & Blood Diseases Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1111/joim.20092
- Citations
- 2
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54